TY - JOUR
T1 - Melatonin as a mitochondria-targeted antioxidant
T2 - one of evolution’s best ideas
AU - Reiter, Russel J.
AU - Rosales-Corral, Sergio
AU - Tan, Dun-xian
AU - Jou, Mei Jie
AU - Galano, Annia
AU - Xu, Bing
N1 - Funding Information:
Acknowledgements This work was supported in part by Grants CMRPD1C0511-3 (from the Chang Gung Memorial Hospital, Taiwan), MOST 105-2320-B-182-011 and MOST 104-2320-B-182-008 (to MJJ).
Publisher Copyright:
© 2017, Springer International Publishing AG.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Melatonin is an ancient antioxidant. After its initial development in bacteria, it has been retained throughout evolution such that it may be or may have been present in every species that have existed. Even though it has been maintained throughout evolution during the diversification of species, melatonin’s chemical structure has never changed; thus, the melatonin present in currently living humans is identical to that present in cyanobacteria that have existed on Earth for billions of years. Melatonin in the systemic circulation of mammals quickly disappears from the blood presumably due to its uptake by cells, particularly when they are under high oxidative stress conditions. The measurement of the subcellular distribution of melatonin has shown that the concentration of this indole in the mitochondria greatly exceeds that in the blood. Melatonin presumably enters mitochondria through oligopeptide transporters, PEPT1, and PEPT2. Thus, melatonin is specifically targeted to the mitochondria where it seems to function as an apex antioxidant. In addition to being taken up from the circulation, melatonin may be produced in the mitochondria as well. During evolution, mitochondria likely originated when melatonin-forming bacteria were engulfed as food by ancestral prokaryotes. Over time, engulfed bacteria evolved into mitochondria; this is known as the endosymbiotic theory of the origin of mitochondria. When they did so, the mitochondria retained the ability to synthesize melatonin. Thus, melatonin is not only taken up by mitochondria but these organelles, in addition to many other functions, also probably produce melatonin as well. Melatonin’s high concentrations and multiple actions as an antioxidant provide potent antioxidant protection to these organelles which are exposed to abundant free radicals.
AB - Melatonin is an ancient antioxidant. After its initial development in bacteria, it has been retained throughout evolution such that it may be or may have been present in every species that have existed. Even though it has been maintained throughout evolution during the diversification of species, melatonin’s chemical structure has never changed; thus, the melatonin present in currently living humans is identical to that present in cyanobacteria that have existed on Earth for billions of years. Melatonin in the systemic circulation of mammals quickly disappears from the blood presumably due to its uptake by cells, particularly when they are under high oxidative stress conditions. The measurement of the subcellular distribution of melatonin has shown that the concentration of this indole in the mitochondria greatly exceeds that in the blood. Melatonin presumably enters mitochondria through oligopeptide transporters, PEPT1, and PEPT2. Thus, melatonin is specifically targeted to the mitochondria where it seems to function as an apex antioxidant. In addition to being taken up from the circulation, melatonin may be produced in the mitochondria as well. During evolution, mitochondria likely originated when melatonin-forming bacteria were engulfed as food by ancestral prokaryotes. Over time, engulfed bacteria evolved into mitochondria; this is known as the endosymbiotic theory of the origin of mitochondria. When they did so, the mitochondria retained the ability to synthesize melatonin. Thus, melatonin is not only taken up by mitochondria but these organelles, in addition to many other functions, also probably produce melatonin as well. Melatonin’s high concentrations and multiple actions as an antioxidant provide potent antioxidant protection to these organelles which are exposed to abundant free radicals.
KW - Apoptosis
KW - Cytochrome c
KW - Free radical-related diseases
KW - Inner mitochondrial membrane
KW - Melatonin transporters
KW - Mitochondrial transition pore
KW - Reactive oxygen species
KW - SIRT3
UR - http://www.scopus.com/inward/record.url?scp=85028763189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028763189&partnerID=8YFLogxK
U2 - 10.1007/s00018-017-2609-7
DO - 10.1007/s00018-017-2609-7
M3 - Review article
C2 - 28864909
AN - SCOPUS:85028763189
SN - 1420-682X
VL - 74
SP - 3863
EP - 3881
JO - Cellular and Molecular Life Sciences
JF - Cellular and Molecular Life Sciences
IS - 21
ER -